Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation.
about
Minor inflammation after surgical evacuation compared with fibrinolytic therapy of experimental intracerebral hemorrhagesMinimally invasive surgery for intracerebral haemorrhage.Comparison of endoscopic evacuation, stereotactic aspiration and craniotomy for the treatment of supratentorial hypertensive intracerebral haemorrhage: study protocol for a randomised controlled trial.Acute effects of intracranial hypertension and ARDS on pulmonary and neuronal damage: a randomized experimental study in pigs.Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema.Stereotactic multiplanar reformatted computed tomography-guided catheter placement and thrombolysis of spontaneous intracerebral hematomasA Viewpoint on Treatment of Traumatic Bilateral Basal Ganglia Hemorrhage in a Child: Case ReportProgress in translational research on intracerebral hemorrhage: is there an end in sight?History of preclinical models of intracerebral hemorrhageOptimization of Catheter Based rtPA Thrombolysis in a Novel In Vitro Clot Model for Intracerebral Hemorrhage.Urokinase vs Tissue-Type Plasminogen Activator for Thrombolytic Evacuation of Spontaneous Intracerebral Hemorrhage in Basal Ganglia.Tissue plasminogen activator induced delayed edema in experimental porcine intracranial hemorrhage: reduction with plasminogen activator inhibitor-1 administration.Image-guided implantation of pre-calibrated catheters in the ICU: a feasibility study.Combination of ultrasound and rtPA enhances fibrinolysis in an In Vitro clot system.No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.No exacerbation of perihematomal edema with intraclot urokinase in patients with spontaneous intracerebral hemorrhage.Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages.
P2860
Q28181833-EB9ABFD8-33CD-4A8D-8606-64D2AA0D3046Q33787257-D0B81193-6B02-4F17-AB7A-D9D0972925C1Q33850820-94FEA8C5-BBE7-45F0-935D-A61AC019D744Q35078940-8EC0D7BD-B0C4-4269-AD18-285599AA748EQ35111618-A49ED61B-F8C4-4C99-A1A9-7F6806E9CDACQ36986254-80145002-F570-465C-8124-3EE5CB5450F7Q37416510-BE01129A-3202-466B-A2BB-1C8375812C0EQ37652936-8608D544-DFE9-45F0-B15B-3F071218B2AFQ37897159-64036B67-C18F-4B7F-8738-D29DB8ADC601Q38811551-8BC1D406-3C31-4250-8BCC-0949D96CCDB8Q41221471-3A34225B-2E41-41D4-9EC7-D2CEB6EDDF73Q41962747-9111865F-3ADB-4628-B26D-472251806A1CQ45373194-C3A42D7D-7287-4428-BE68-8A7F8FD75016Q47128286-2EF3A708-CC90-405B-8421-8C299C3535C0Q48138425-4E5FE7F5-8A9F-462B-AB6E-6E18DCD21848Q48766747-1EBCACF8-CBF0-4FB1-95C0-EE84E955B78FQ52098871-940F60AB-BA2E-4A2D-8355-834CBA47142CQ53804931-AD3E1F92-8551-4A04-9C89-17AEDAD035C4
P2860
Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Fibrinolysis therapy achieved ...... on of delayed edema formation.
@en
type
label
Fibrinolysis therapy achieved ...... on of delayed edema formation.
@en
prefLabel
Fibrinolysis therapy achieved ...... on of delayed edema formation.
@en
P2093
P1476
Fibrinolysis therapy achieved ...... on of delayed edema formation.
@en
P2093
Azize Ince
Carina Röttger
Gregor Dückers
Harald D Müller
Klaus Gröschel
Ruth Thiex
Wilhelm Küker
P304
P356
10.3171/JNS.2002.97.4.0954
P407
P577
2002-10-01T00:00:00Z